Totally agree!

I watch Ray being interviewd & he hardly could explain the science behind the ABET clearly!!

These physician/investigators are never in touch with the silence at deepest level. They just look at the winners / losers targets, all based on trial designs.

its unfortunate that they don’t see it as a fishing trial,...: let’s see among all of those targets, which is being affected by the drug... rather than,... well primary failed, thus, all is bad or may be bad....

All trials looking at novel molecules should be absolutely looking at multiple targets without defining any as primary!!!

On top of that, the investigators have their hands in multiple pies & don’t want to rock the boat. Friends with all..,